2957 Recruiting Trials

Clinical Trials for Breast Cancer

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

Showing 15 of 2957 recruiting trials

AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
NA Brussels +4 more NCT02102165
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
PHASE3 Tucson, Arizona +4 more NCT05232916
Recruiting
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
PHASE1 Fullerton, California +4 more NCT05386108
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
PHASE2 Birmingham, Alabama +4 more NCT05564377
Recruiting
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NA Seattle, Washington +4 more NCT05874297
Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
PHASE1 Duarte, California +4 more NCT05877599
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Tucson, Arizona +4 more NCT06058377
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
PHASE1 Denver, Colorado +4 more NCT06120283
Recruiting
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
PHASE2 Cleveland, Ohio +4 more NCT06129747
Recruiting
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
PHASE2 Miami, Florida +4 more NCT06176261
Recruiting
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
PHASE1 Saint Louis, Missouri +4 more NCT06188520
Recruiting
A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies
PHASE4 Anderlecht +4 more NCT06274515
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
PHASE1 Los Angeles, California +4 more NCT06324357
Recruiting
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
PHASE2 Boston, Massachusetts +4 more NCT06439693
Recruiting
Breast Cancer PSMA PET
EARLY_PHASE1 Iowa City, Iowa +4 more NCT06586047
Recruiting
See all 2957 results

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon